Elizabeth Talker

Employment

• Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre Senior research fellow
  2021 - Present
• Advanced Centre for treatment research and education in cancer Scientific Officer
  2018 - 2021

Education

• University of Pennsylvania PhD in genetics and epigenetics, BGS-CAMB
  2025 - Present
• Hebrew University of Jerusalem Ph.D
  2023 - Present
• Advanced Centre for Treatment, Research and Education in Cancer M.Sc. Dissertation
  2017 - 2018
• Grant Medical College and Sir Jamshedjee Jeejeebhoy Group of Hospitals Intern
  2014 - 2014

Projects & Funding

Projects & funding information is unavailable.

Publications (21)

• Genomic landscape of hormone therapy-resistant HR-positive, HER2-negative breast cancer
  Breast Cancer Research and Treatment 2025 8 citations DOI: 10.1007/s10549-025-07759-7
  +Save
• Circulating tumour DNA as a promising biomarker for breast cancer diagnosis & treatment monitoring
  The Indian Journal of Medical Research 2025 6 citations DOI: 10.25259/ijmr_1291_2024
  +Save
• Patient derived xenograft models of hormone receptor positive and HER2 negative breast cancer from Indian patients
  Scientific Reports 2025 0 citations DOI: 10.1038/s41598-025-22361-z
  +Save
• Surgical Tumor Resection Deregulates Hallmarks of Cancer in Resected Tissue and the Surrounding Microenvironment
  Molecular Cancer Research 2024 5 citations DOI: 10.1158/1541-7786.mcr-23-0265
  +Save
• A novel amplification of JAK2 in a case of relapsed pediatric B-ALL
  2024 0 citations DOI: 10.22541/au.170669017.79417715/v1
  +Save
• Isolation of agarose digesting Achromobacter sp. and Brevundimonas diminuta using customized earthworm gut as an enrichment system
  Journal of Environmental Biology 2023 0 citations DOI: 10.22438/jeb/44/1/mrn-4065
  +Save
• • Copy number gain of JAK2 on a marker chromosome in a case of relapsed pediatric B-ALL.
  Pediatric blood and cancer 2022
  +Save
• • Importance of conventional cytogenetics in the identification of ins(19;X)(q13.1;p11.2q28) and t(1;11)(q10;p10), both, novel cytogenetic abnormalities in a pediatric AML case
  Cancer genetics 2021
  +Save
• • Additional cytogenetic aberrations indicative of poor prognosis in AML with RUNX1/RUNX1T1 rearrangement: karyotype a chromosomal blueprint
  Annals of hematology and oncology. 2021
  +Save
• Highlights: Karyotyping-An Overview Fluorescence In-situ Hybridization Polymerase Chain Reaction: Tool for Genomics Analysis Sanger Sequencing-The Gold Standard Game Changer-Next Generation Sequencing Technology
  MPAI e_newsletter 2021
  +Save